Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mass Balance Study of 14C-RAY1225 Injection in Healthy Chinese Participants

NCT07460284 is registered in ClinicalTrials.gov with Guangdong Raynovent Biotech Co., Ltd as lead sponsor.

NCT NCT07460284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07460284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mass Balance Study of 14C-RAY1225 Injection in Healthy Chinese Participants
Lead sponsor
Guangdong Raynovent Biotech Co., Ltd
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
October 28, 2026
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basic science